Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Suspended NCT06616649

Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.

Conditions: Peripheral Neuropathy Due to Chemotherapy

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 10
Sponsor: M.D. Anderson Cancer Center

Location: The University of Texas MD Anderson Cancer Center Houston Texas

Summary

To explore the benefits of using closed loop spinal cord stimulation (SCS) in the treatment of patients experiencing painful chemotherapy induced peripheral neuropathy (CIPN) by assessing changes in pain, quality of life, pain medication use, sensory improvement through quantitative sensory testing, and improvement of gait through quantitative gait testing.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years * Diagnosis history of CIPN of lower extremities * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of SCS * Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: * Patients undergoing active chemotherapy or immunotherapy * Patients undergoing medical litigation. * Patients with active infection, being treated with antibiotics * Patients that are pregnant or planning to conceive * Patients who are receiving any investigational agents. * Patients with brain metastases. * Patients with cognitive impairment/psychiatric illness/social situations that would limit compliance with study requirements. * Patients with history of alternative forms of sensorimotor neuropathies prior to CIPN presentation

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06616649). StuddyBuddy aggregates publicly available trial information.